Literature DB >> 33814609

Amiodarone Extraction by the Extracorporeal Membrane Oxygenation Circuit.

C Griffin McDaniel1, C Cole Honeycutt1, Kevin M Watt1.   

Abstract

Amiodarone is an anti-arrhythmic agent that is frequently used to treat tachycardias in critically ill adults and children. Because of physicochemical properties of amiodarone, extracorporeal membrane oxygenation (ECMO) circuits are expected to extract amiodarone from circulation, increasing the risk of therapeutic failure. The present study seeks to determine amiodarone extraction by the ECMO circuit. Amiodarone was administered to three ex vivo circuit configurations (n = 3 per configuration) to determine the effect of each circuit component on drug extraction. The circuits were primed with human blood; standard amiodarone doses were administered; and serial samples were collected over 24 hours. Additional circuits were primed with crystalloid fluid to analyze the effect of blood on extraction and to investigate circuit saturation by drug. The crystalloid circuits were dosed multiple times over 72 hours, including a massive dose at 48 hours. For both setups, the flow was set to 1 L/min. Drug was added to separate tubes containing the prime solution to serve as controls. Drug concentrations were quantified with a validated assay, and drug recovery was calculated for each sample. Mean recovery for the circuits and controls were compared to correct for drug degradation over time. Amiodarone was heavily extracted by all ECMO circuit configurations. Eight hours after dosing, mean recovery in the blood prime circuits was 13.5-22.1%. In the crystalloid prime circuits, drug recovery decreased even more rapidly, with a mean recovery of 22.0% at 30 minutes. Similarly, drug recovery decreased more quickly in the crystalloid prime controls than in the blood prime controls. Saturation was not achieved in the crystalloid prime circuits, as final amiodarone concentrations were at the lower limit of quantification. The results suggest that amiodarone is rapidly extracted by the ECMO circuit and that saturation is not achieved by standard doses. In vivo circuit extraction may cause decreased drug exposure. © Copyright 2021 AMSECT.

Entities:  

Keywords:  amiodarone; drug extraction; extracorporeal membrane oxygenation; pharmacokinetics

Year:  2021        PMID: 33814609      PMCID: PMC7995631          DOI: 10.1182/ject-2000053

Source DB:  PubMed          Journal:  J Extra Corpor Technol        ISSN: 0022-1058


  40 in total

1.  Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory review.

Authors:  P Zhao; L Zhang; J A Grillo; Q Liu; J M Bullock; Y J Moon; P Song; S S Brar; R Madabushi; T C Wu; B P Booth; N A Rahman; K S Reynolds; E Gil Berglund; L J Lesko; S-M Huang
Journal:  Clin Pharmacol Ther       Date:  2010-12-29       Impact factor: 6.875

2.  Early experience with low-prime (99 ml) extracorporeal membrane oxygenation support in children.

Authors:  Yasumori Yamasaki; Teruyuki Hayashi; Takeshi Nakatani; Hideki Yotsuida; Takayuki Nishigaki; Yuzo Takahashi; Shuji Inamori; Kuji Kagisaki; H Hagino; T Ishizaka; Toshikatsu Yagihara
Journal:  ASAIO J       Date:  2006 Jan-Feb       Impact factor: 2.872

3.  Population pharmacokinetics of midazolam and its metabolites during venoarterial extracorporeal membrane oxygenation in neonates.

Authors:  Maurice J Ahsman; Manon Hanekamp; Enno D Wildschut; Dick Tibboel; Ron A A Mathot
Journal:  Clin Pharmacokinet       Date:  2010-06       Impact factor: 6.447

4.  Serum concentrations of amiodarone during long term therapy. Relation to dose, efficacy and toxicity.

Authors:  M Stäubli; J Bircher; R L Galeazzi; H Remund; H Studer
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

5.  A rapid procedure for the monitoring of amiodarone and N-desethylamiodarone by HPLC-UV detection.

Authors:  JoEtta M Juenke; Paul I Brown; Gwendolyn A McMillin; Francis M Urry
Journal:  J Anal Toxicol       Date:  2004 Jan-Feb       Impact factor: 3.367

6.  Evaluation of furosemide regimens in neonates treated with extracorporeal membrane oxygenation.

Authors:  Maria M J van der Vorst; Enno Wildschut; Robbert J Houmes; Saskia J Gischler; Joana E Kist-van Holthe; Jacobus Burggraaf; Albert J van der Heijden; Dick Tibboel
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

7.  Propofol, midazolam, vancomycin and cyclosporine therapeutic drug monitoring in extracorporeal membrane oxygenation circuits primed with whole human blood.

Authors:  Florian Lemaitre; Nesrine Hasni; Pascal Leprince; Emmanuel Corvol; Ghassen Belhabib; Pierre Fillâtre; Charles-Edouard Luyt; Cyril Leven; Robert Farinotti; Christine Fernandez; Alain Combes
Journal:  Crit Care       Date:  2015-02-12       Impact factor: 9.097

8.  We urgently need guidelines for managing COVID-19 in children with comorbidities.

Authors:  Devi Dayal
Journal:  Acta Paediatr       Date:  2020-05-06       Impact factor: 2.299

9.  Physiologically Based Pharmacokinetic Approach to Determine Dosing on Extracorporeal Life Support: Fluconazole in Children on ECMO.

Authors:  Kevin M Watt; Michael Cohen-Wolkowiez; Jeffrey S Barrett; Michael Sevestre; Ping Zhao; Kim L R Brouwer; Andrea N Edginton
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2018-08-13

10.  Antifungal Extraction by the Extracorporeal Membrane Oxygenation Circuit.

Authors:  Kevin M Watt; Michael Cohen-Wolkowiez; Duane C Williams; Desiree K Bonadonna; Ira M Cheifetz; Dhiren Thakker; Daniel K Benjamin; Kim L R Brouwer
Journal:  J Extra Corpor Technol       Date:  2017-09
View more
  2 in total

1.  Impaired Pharmacokinetics of Amiodarone under Veno-Venous Extracorporeal Membrane Oxygenation: From Bench to Bedside.

Authors:  Mickaël Lescroart; Claire Pressiat; Benjamin Péquignot; N'Guyen Tran; Jean-Louis Hébert; Nassib Alsagheer; Nicolas Gambier; Bijan Ghaleh; Julien Scala-Bertola; Bruno Levy
Journal:  Pharmaceutics       Date:  2022-04-30       Impact factor: 6.525

2.  Protective Role of Amiodarone on Reperfusion Arrhythmia in Patients of Acute Myocardial Infarction with Percutaneous Coronary Intervention Treatment.

Authors:  Jianying Wang; Jinchang Leng; Xiaowei Sun; Kun Peng; Xaojuan Ma; Shiqin Huang; Fang Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-26       Impact factor: 2.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.